Treatment and Prevention of HIV-Associated Tuberculosis is organized by International Antiviral Society-USA (IAS-USA) and will be held on Dec 16, 2024.
Description:
Globally, tuberculosis (TB) is the most common opportunistic infection in people living with HIV. Many coinfected patients first present with advanced immunosuppression and require antiretroviral therapy (ART) initiation during TB treatment. The incidence of TB in patients established on ART remains high. Cotreatment presents several management challenges. Recent data on these treatment, prevention, and management issues are reviewed.
Learning Objectives
On completion of this activity, learners will be able to:
Additional details will be posted as soon as information is available.
CME Credits:
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points:
ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.
Nursing Credits:
This activity is eligible for ANCC credit, see final CNE activity announcement for specific details.
Pharmacy Credits:
Accreditation Council for Pharmacy Education logoThis activity is eligible for ACPE credit, see final CPE activity announcement for specific details.
Grant Support:
This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from ineligible companies. Per IAS–USA policy, any effort that uses grants from ineligible companies must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved